Editorial introductions.

Abstract

Current Opinion in Pulmonary Medicine was launched in 1995. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of pulmonary medicine is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Alan FeinAlan FeinAlan Fein, MD received his medical degree from the State University of New York Downstate Medical Center in Brooklyn, USA in 1973. He completed his internship and residency in internal medicine at Albert Einstein College of Medicine, Bronx Municipal Hospital, New York, USA. From there, Dr Fein moved on to a fellowship in Pulmonary Disease at the University of California, San Francisco Cardiovascular Research Institute, USA. He served as Division Chief for Sleep, Pulmonary & Critical Care Medicine at Winthrop Hospital and then for the North Shore Long Island Jewish Health System. Dr Fein is a member of the American Academy of Sleep Medicine, the American College of Chest Physicians, the American College of Physicians, and the American College of Critical Care Medicine. He is the former President of the American Lung Association of Nassau/Suffolk and served on the national boards of the American Thoracic Society and the American College of Chest Physicians. Dr Fein is a Clinical Professor of Medicine at New York University, USA and Zucker School of Medicine, USA. He was Chief of the Pulmonary, Critical and Sleep Division of Prohealthcare Associates Optum Health. He is currently Medical director of the Post Covid Recovery Center for Optum Health. Dr Fein is on the editorial boards of Current Opinion in Pulmonary Medicine and the American Journal of Respiratory & Critical Care Medicine. Dr Fein has authored almost 100 peer-reviewed manuscripts, over 100 review articles, and book chapters on topics such as diagnosis and treatment of lung cancer, pneumonia, asthma, and chronic obstructive pulmonary diseases. David E. OstDavid E. OstDavid E. Ost, MD, MPH is Professor of Medicine at The University of Texas M. D. Anderson Cancer Center, Department of Pulmonary Medicine, USA. Dr Ost is a Fellow of the American College of Chest Physicians and the American College of Physicians and has served on the board of directors of the American Association of Bronchology and Interventional Pulmonology. Dr Ost is currently editor of the Journal of Bronchology and Interventional Pulmonology. He is a reviewer for many journals including Annals of Internal Medicine, the American Journal of Respiratory and Critical Care Medicine, Chest and the Journal of the American Medical Association. Dr Ost has authored over 100 manuscripts and book chapters on such topics as interventional pulmonology, lung cancer, pulmonary embolism, and ventilator associated pneumonia. Dr Ost received his medical degree from the Thomas Jefferson University, Jefferson Medical College in Philadelphia, USA. He completed his internship and residency in internal medicine at Northwestern University in Chicago, USA. Additionally, Dr Ost was a fellow in pulmonary and critical care at Northwestern. He is board certified in interventional pulmonology. He received his Masters in Public Health from Harvard University, USA, with a focus in quantitative methods. Aalt BastAalt BastProf. Aalt Bast studied chemistry at the Free University in Amsterdam, the Netherlands. His PhD study (on biotransformation enzymes) was conducted at the Erasmus University of Rotterdam (Faculty of Medicine), the Netherlands, and at the University of Utrecht (Faculty of Pharmacy), Netherlands. He was Professor of Molecular Pharmacology at the Department of Pharmacochemistry at the Free University in Amsterdam in 1988. In 1998, he started to work as professor of Human Toxicology at the Maastricht University, the Netherlands. His main field of interest is the role of free radicals in drug toxicity and pathologies of the lung and the cardiovascular system. Moreover, the possibilities for therapeutic intervention with antioxidants (from food or as drugs) are explored. His current position is Dean of the Campus Venlo, a satellite of Maastricht University. He is registered in the Netherlands as an experimental pharmacologist and toxicologist. He (co-) authored over 650 papers and book chapters. He was chairman of the Dutch Toxicological Society, member of the Concilium Toxicologicum and member of the National Health Council.